Dietary phenethyl isothiocyanate alters gene expression in human breast cancer cells

Young Jin Moon1, Daniel A Brazeau, Marilyn E Morris

  • 1Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, NY 14260, USA.

Insights

Phenethyl isothiocyanate (PEITC) alters gene expression in breast cancer cells, potentially explaining its cancer-blocking effects. This study identified key genes involved in tumor suppression and cell proliferation affected by PEITC treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Phenethyl isothiocyanate (PEITC), found in cruciferous vegetables, exhibits chemopreventive properties demonstrated in animal models.
  • Understanding the molecular mechanisms of PEITC's chemopreventive effects is crucial for its therapeutic application.
  • MCF-7 human breast cancer cells provide a relevant model for studying PEITC's impact on cancer-related gene expression.

Purpose of the Study:

  • To investigate the effects of PEITC on gene expression profiles in MCF-7 human breast cancer cells.
  • To identify specific genes and pathways modulated by PEITC that contribute to its chemopreventive potential.
  • To elucidate the molecular mechanisms underlying PEITC's anti-cancer activity.

Main Methods:

  • MCF-7 cells were treated with PEITC (3 μM) or vehicle for 48 hours.
  • Total RNA was extracted for microarray analysis using human GE Array Kits focusing on signal transduction and cancer/tumor suppression genes.
  • Gene expression data from treated and control groups (n=4 per group) were analyzed using a Student's t-test.

Main Results:

  • PEITC treatment significantly induced the expression of several key genes: tumor protein p53 (p53), cyclin-dependent kinase inhibitor 1C (p57 Kip2), breast cancer Type 2 early onset (BRCA2), cAMP responsive element binding protein 2 (ATF-2), interleukin 2 (IL-2), heat shock 27 KD protein (hsp27), and CYP19 (aromatase).
  • Upregulation of p57 Kip2, p53, BRCA2, IL-2, and ATF-2 suggests potential roles in decreasing cellular proliferation and enhancing tumor suppression or apoptosis.
  • Significant alterations in genes related to tumor suppression and cellular proliferation/apoptosis were observed.

Conclusions:

  • PEITC significantly impacts the expression of genes involved in critical cellular processes relevant to cancer.
  • The observed gene expression changes, particularly the induction of tumor suppressor and apoptosis-related genes, provide a molecular basis for PEITC's chemopreventive effects.
  • Further research into these specific gene alterations may reveal novel therapeutic strategies utilizing PEITC for breast cancer prevention or treatment.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...